Lilly Evista sales force recruitment by Management Recruitment, Inc. reprises Zyprexa strategy.
Executive Summary
LILLY EVISTA SALES FORCE RECRUITMENT BY MANAGEMENT RECRUITMENT, INC. will seek to duplicate the approach used by Lilly to bolster its sales force for the launch of Zyprexa. The company will hire new sales representatives in anticipation of a June submission of Evista (raloxifene) to FDA for treatment of postmenopausal women at risk for osteoporosis, and a 1998 submission for the treatment of established osteoporosis. MRI helped Lilly add 100 sales reps for the launch of the antipsychotic Zyprexa in October.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth